医药-话题@MedSci

#医药#

1668篇内容 | 3309人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1410138, encodeId=94f81410138ef, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=重磅！6所中医药大学正在新建或筹建！, objectType=article, longId=213098, objectId=55dd213098c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55dd213098c2, replyNumber=0, likeNumber=81, createdTime=2021-06-25, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55dd213098c2, moduleTitle=重磅！6所中医药大学正在新建或筹建！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55dd213098c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410137, encodeId=ca79141013e64, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=亚盛医药APG-2575临床优势初显，国内首家Bcl-2抑制剂用于CLL/SLL前景无限, objectType=article, longId=212474, objectId=868f2124e4b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=868f2124e4b8, replyNumber=0, likeNumber=84, createdTime=2021-06-10, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=868f2124e4b8, moduleTitle=亚盛医药APG-2575临床优势初显，国内首家Bcl-2抑制剂用于CLL/SLL前景无限, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=868f2124e4b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410136, encodeId=7f001410136fb, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=征祥医药完成2亿元A+轮融资，推进肿瘤，流感等管线, objectType=article, longId=212371, objectId=f4312123e164, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4312123e164, replyNumber=0, likeNumber=57, createdTime=2021-06-08, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4312123e164, moduleTitle=征祥医药完成2亿元A+轮融资，推进肿瘤，流感等管线, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4312123e164)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410135, encodeId=6899141013571, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=中国工程院2021年院士增选第二轮候选人名单公布，医药卫生学部共34人, objectType=article, longId=212203, objectId=77c1212203f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77c1212203f6, replyNumber=0, likeNumber=0, createdTime=2021-06-04, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77c1212203f6, moduleTitle=中国工程院2021年院士增选第二轮候选人名单公布，医药卫生学部共34人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77c1212203f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410134, encodeId=9c7114101348e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=2021年中国医药行业十大趋势, objectType=article, longId=211822, objectId=98ea21182280, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98ea21182280, replyNumber=0, likeNumber=84, createdTime=2021-05-27, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98ea21182280, moduleTitle=2021年中国医药行业十大趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98ea21182280)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410157, encodeId=ed4e141015eae, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=助力健康中国，服务患者，构建医药新生态：瀚晖制药与上药控股优势叠加，达成战略合作, objectType=article, longId=211810, objectId=c8ab211810e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8ab211810e4, replyNumber=0, likeNumber=67, createdTime=2021-05-27, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8ab211810e4, moduleTitle=助力健康中国，服务患者，构建医药新生态：瀚晖制药与上药控股优势叠加，达成战略合作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8ab211810e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410132, encodeId=05a2141013289, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=山东慈济医院揭牌搭建两岸中医药交流新平台, objectType=article, longId=211122, objectId=c34d21112249, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c34d21112249, replyNumber=0, likeNumber=62, createdTime=2021-05-13, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c34d21112249, moduleTitle=山东慈济医院揭牌搭建两岸中医药交流新平台, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c34d21112249)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410131, encodeId=4c321410131cc, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=复星医药/BioNTech在中国设立合资公司：mRNA新冠疫苗复必泰年产能达10亿剂，预计7月前被国内批准上市, objectType=article, longId=211050, objectId=500e2110502a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=500e2110502a, replyNumber=0, likeNumber=73, createdTime=2021-05-11, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=500e2110502a, moduleTitle=复星医药/BioNTech在中国设立合资公司：mRNA新冠疫苗复必泰年产能达10亿剂，预计7月前被国内批准上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=500e2110502a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410142, encodeId=dc711410142ff, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=EQT私募股权投资基金和高盛资产管理公司与精鼎医药达成收购协议, objectType=article, longId=210480, objectId=8873210480eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8873210480eb, replyNumber=0, likeNumber=69, createdTime=2021-04-27, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8873210480eb, moduleTitle=EQT私募股权投资基金和高盛资产管理公司与精鼎医药达成收购协议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8873210480eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410129, encodeId=626514101293e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=中国工程院2021年院士增选577位有效候选人名单公布，其中医药卫生部84位有效候选人, objectType=article, longId=210385, objectId=e5f921038592, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5f921038592, replyNumber=0, likeNumber=72, createdTime=2021-04-25, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5f921038592, moduleTitle=中国工程院2021年院士增选577位有效候选人名单公布，其中医药卫生部84位有效候选人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5f921038592)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410133, encodeId=1e3a141013371, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=ISR发布CRO II/III期基准报告，精鼎医药在多项评估中名列前茅, objectType=article, longId=210361, objectId=0a702103613f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a702103613f, replyNumber=0, likeNumber=63, createdTime=2021-04-25, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a702103613f, moduleTitle=ISR发布CRO II/III期基准报告，精鼎医药在多项评估中名列前茅, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a702103613f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410130, encodeId=adec141013061, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=【今晚19:00直播】成都中医药大学附属医院孔令秋教授：60分钟讲透超声心动图, objectType=article, longId=210279, objectId=77572102e96b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77572102e96b, replyNumber=0, likeNumber=46, createdTime=2021-04-23, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77572102e96b, moduleTitle=【今晚19:00直播】成都中医药大学附属医院孔令秋教授：60分钟讲透超声心动图, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77572102e96b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410128, encodeId=277a141012815, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=2021药物创新与药品监管大变局，中国特色医药监管体系初现, objectType=article, longId=210187, objectId=907521018e22, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=907521018e22, replyNumber=0, likeNumber=80, createdTime=2021-04-21, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=907521018e22, moduleTitle=2021药物创新与药品监管大变局，中国特色医药监管体系初现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=907521018e22)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410177, encodeId=fbd214101e715, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=阿斯利康全球研发中国中心正式开幕，助力上海打造**生物医药产业高地 , objectType=article, longId=210135, objectId=92c82101353f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92c82101353f, replyNumber=0, likeNumber=53, createdTime=2021-04-20, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92c82101353f, moduleTitle=阿斯利康全球研发中国中心正式开幕，助力上海打造**生物医药产业高地 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92c82101353f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410150, encodeId=8ea614101506b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=精鼎医药携手中国医学科学院肿瘤医院建立临床开发创新合作：以患者为中心，提升临床试验的可及性和效率, objectType=article, longId=209986, objectId=90ad209986a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90ad209986a8, replyNumber=0, likeNumber=83, createdTime=2021-04-16, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90ad209986a8, moduleTitle=精鼎医药携手中国医学科学院肿瘤医院建立临床开发创新合作：以患者为中心，提升临床试验的可及性和效率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90ad209986a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410178, encodeId=407b14101e836, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=精鼎医药任命前GSK高管Stephen Pyke，为临床数据和数字化服务能力加码, objectType=article, longId=209841, objectId=90a220984160, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90a220984160, replyNumber=0, likeNumber=105, createdTime=2021-04-13, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90a220984160, moduleTitle=精鼎医药任命前GSK高管Stephen Pyke，为临床数据和数字化服务能力加码, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90a220984160)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410148, encodeId=4077141014843, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=精鼎医药与北京病痛挑战公益基金会建立创新合作，助力提升患者在临床试验中的体验, objectType=article, longId=209815, objectId=a6962098152d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6962098152d, replyNumber=0, likeNumber=0, createdTime=2021-04-12, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6962098152d, moduleTitle=精鼎医药与北京病痛挑战公益基金会建立创新合作，助力提升患者在临床试验中的体验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6962098152d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410126, encodeId=5aa4141012625, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=全球化布局医美高端产品，华东医药“鲶鱼效应”搅动一池春水, objectType=article, longId=209554, objectId=f6302095542d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6302095542d, replyNumber=0, likeNumber=66, createdTime=2021-04-05, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6302095542d, moduleTitle=全球化布局医美高端产品，华东医药“鲶鱼效应”搅动一池春水, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6302095542d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410125, encodeId=10a4141012538, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=官宣：新增3所医药类公办本科院校和41个备案审批药学相关本科专业, objectType=article, longId=209497, objectId=635520949e3c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=635520949e3c, replyNumber=0, likeNumber=62, createdTime=2021-04-05, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=635520949e3c, moduleTitle=官宣：新增3所医药类公办本科院校和41个备案审批药学相关本科专业, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=635520949e3c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410124, encodeId=fa4e14101242d, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=思路迪医药获新一代CD47抗体新药大中华区**授权, objectType=article, longId=209469, objectId=aa2920946911, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa2920946911, replyNumber=0, likeNumber=101, createdTime=2021-04-05, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa2920946911, moduleTitle=思路迪医药获新一代CD47抗体新药大中华区**授权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa2920946911)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

医药

2020-05-29

cathymary (审核中...)

前往app查看评论内容

#医药#

重磅！6所中医药大学正在新建或筹建！

2021-06-25

cathymary (审核中...)

前往app查看评论内容

#医药#

亚盛医药APG-2575临床优势初显，国内首家Bcl-2抑制剂用于CLL/SLL前景无限

2021-06-10

cathymary (审核中...)

前往app查看评论内容

#医药#

征祥医药完成2亿元A+轮融资，推进肿瘤，流感等管线

2021-06-08

zhaojie88 (审核中...)

前往app查看评论内容

#医药#

中国工程院2021年院士增选第二轮候选人名单公布，医药卫生学部共34人

2021-06-04

cathymary (审核中...)

前往app查看评论内容

#医药#

2021年中国医药行业十大趋势

2021-05-27

cathymary (审核中...)

前往app查看评论内容

#医药#

助力健康中国，服务患者，构建医药新生态：瀚晖制药与上药控股优势叠加，达成战略合作

2021-05-27

cathymary (审核中...)

前往app查看评论内容

#医药#

山东慈济医院揭牌搭建两岸中医药交流新平台

2021-05-13

cathymary (审核中...)

前往app查看评论内容

#医药#

复星医药/BioNTech在中国设立合资公司：mRNA新冠疫苗复必泰年产能达10亿剂，预计7月前被国内批准上市

2021-05-11

cathymary (审核中...)

前往app查看评论内容

#医药#

EQT私募股权投资基金和高盛资产管理公司与精鼎医药达成收购协议

2021-04-27

cathymary (审核中...)

前往app查看评论内容

#医药#

中国工程院2021年院士增选577位有效候选人名单公布，其中医药卫生部84位有效候选人

2021-04-25

cathymary (审核中...)

前往app查看评论内容

#医药#

ISR发布CRO II/III期基准报告，精鼎医药在多项评估中名列前茅

2021-04-25

cathymary (审核中...)

前往app查看评论内容

#医药#

【今晚19:00直播】成都中医药大学附属医院孔令秋教授：60分钟讲透超声心动图

2021-04-23

cathymary (审核中...)

前往app查看评论内容

#医药#

2021药物创新与药品监管大变局，中国特色医药监管体系初现

2021-04-21

cathymary (审核中...)

前往app查看评论内容

#医药#

阿斯利康全球研发中国中心正式开幕，助力上海打造**生物医药产业高地

2021-04-20

cathymary (审核中...)

前往app查看评论内容

#医药#

精鼎医药携手中国医学科学院肿瘤医院建立临床开发创新合作：以患者为中心，提升临床试验的可及性和效率

2021-04-16

cathymary (审核中...)

前往app查看评论内容

#医药#

精鼎医药任命前GSK高管Stephen Pyke，为临床数据和数字化服务能力加码

2021-04-13

cathymary (审核中...)

前往app查看评论内容

#医药#

精鼎医药与北京病痛挑战公益基金会建立创新合作，助力提升患者在临床试验中的体验

2021-04-12

cathymary (审核中...)

前往app查看评论内容

#医药#

全球化布局医美高端产品，华东医药“鲶鱼效应”搅动一池春水

2021-04-05

cathymary (审核中...)

前往app查看评论内容

#医药#

官宣：新增3所医药类公办本科院校和41个备案审批药学相关本科专业

2021-04-05

cathymary (审核中...)

前往app查看评论内容

#医药#

思路迪医药获新一代CD47抗体新药大中华区**授权

2021-04-05

科室
- - 订阅+
  - 更多科室
工具
服务